Why the study?
Do small interfering RNAs (siRNAs) targeting HAV nonstructural genes reduce viral infectivity in HAV-infected Huh-7 cells?
Do small interfering RNAs (siRNAs) targeting HAV nonstructural genes reduce viral infectivity in HAV-infected Huh-7 cells?
Consecutive applications of siRNA targeting a specific hairpin structure in the HAV genome can efficiently suppress viral infectivity in vitro, suggesting potential as a therapeutic tool for severe HAV infection.
May warrant preclinical testing of multi-siRNA regimens for HAV; leaves open any clinical translation from cell-culture data.
Infection by hepatitis A virus (HAV) can cause acute hepatitis and, rarely, fulminant liver failure, in particular in patients chronically infected with hepatitis C virus. Based on our previous observation that small interfering RNAs (siRNAs) can silence translation and replication of the firefly luciferase-encoding HAV replicon, we now exploited this technology to demonstrate the effect of siRNAs on viral infection in Huh-7 cells. Freshly and persistently infected cells were transfected with siRNAs targeting various sites in the HAV nonstructural genes. Compared to a single application, consecutive siRNA transfections targeting multiple sequences in the viral genome resulted in a more efficient and sustained silencing effect than a single transfection. In most instances, multiple applications of a single siRNA led to the emergence of viral escape mutants with mutated target sites that rendered these genomes resistant to RNA interference (RNAi). Efficient and sustained suppression of the viral infectivity was achieved after consecutive applications of an siRNA targeting a computer-predicted hairpin structure. This siRNA holds promise as a therapeutic tool for severe courses of HAV infection. In addition, the results provide new insight into the structural bases for sequence-specific RNAi.
No takes yet. Share an insight, caveat, or question.
Kusov et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: